10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $225,891 | -0.3% | 4,060 | 0.0% | 0.04% | -10.9% |
| Q1 2023 | $226,507 | +13.0% | 4,060 | 0.0% | 0.05% | +17.9% |
| Q4 2022 | $200,379 | -38.9% | 4,060 | -5.8% | 0.04% | -26.4% |
| Q1 2022 | $328,000 | -49.0% | 4,310 | 0.0% | 0.05% | -41.8% |
| Q4 2021 | $643,000 | +2.1% | 4,310 | +0.2% | 0.09% | -1.1% |
| Q3 2021 | $630,000 | -58.8% | 4,300 | -44.9% | 0.09% | -42.5% |
| Q2 2021 | $1,529,000 | +46.9% | 7,800 | +35.7% | 0.16% | -0.6% |
| Q1 2021 | $1,041,000 | -46.5% | 5,750 | -58.2% | 0.16% | -49.2% |
| Q4 2020 | $1,947,000 | +22.4% | 13,750 | +7.8% | 0.32% | -3.6% |
| Q3 2020 | $1,591,000 | +39.7% | 12,750 | 0.0% | 0.33% | +5.8% |
| Q2 2020 | $1,139,000 | – | 12,750 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |